IS5788A - Pharmacological use of NAB1 and NAB2 - Google Patents

Pharmacological use of NAB1 and NAB2

Info

Publication number
IS5788A
IS5788A IS5788A IS5788A IS5788A IS 5788 A IS5788 A IS 5788A IS 5788 A IS5788 A IS 5788A IS 5788 A IS5788 A IS 5788A IS 5788 A IS5788 A IS 5788A
Authority
IS
Iceland
Prior art keywords
nab1
nab2
pharmacological use
pharmacological
Prior art date
Application number
IS5788A
Other languages
Icelandic (is)
Inventor
Braddock Martin
Jeffrey Campbell Callum
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9814989.1A external-priority patent/GB9814989D0/en
Priority claimed from GBGB9819826.0A external-priority patent/GB9819826D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS5788A publication Critical patent/IS5788A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IS5788A 1998-07-11 2000-12-22 Pharmacological use of NAB1 and NAB2 IS5788A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9814989.1A GB9814989D0 (en) 1998-07-11 1998-07-11 Gene therapy method
GBGB9819826.0A GB9819826D0 (en) 1998-09-12 1998-09-12 Gene therapy method
PCT/GB1999/002199 WO2000003014A1 (en) 1998-07-11 1999-07-09 Pharmaceutical uses of nab1 and nab2

Publications (1)

Publication Number Publication Date
IS5788A true IS5788A (en) 2000-12-22

Family

ID=26314007

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5788A IS5788A (en) 1998-07-11 2000-12-22 Pharmacological use of NAB1 and NAB2

Country Status (22)

Country Link
EP (1) EP1097200A1 (en)
JP (1) JP2002520020A (en)
KR (1) KR20010071832A (en)
CN (1) CN1317045A (en)
AP (1) AP2001002038A0 (en)
AU (1) AU763713B2 (en)
BR (1) BR9912018A (en)
CA (1) CA2336805A1 (en)
EA (1) EA200100028A1 (en)
EE (1) EE200100020A (en)
HR (1) HRP20010025A2 (en)
HU (1) HUP0102835A3 (en)
ID (1) ID27742A (en)
IL (1) IL140533A0 (en)
IS (1) IS5788A (en)
NO (1) NO20010166L (en)
NZ (1) NZ509174A (en)
PL (1) PL345507A1 (en)
SK (1) SK382001A3 (en)
TR (1) TR200100622T2 (en)
WO (1) WO2000003014A1 (en)
YU (1) YU1901A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928430D0 (en) * 1999-12-01 2000-01-26 Glaxo Group Ltd Screening
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004083435A1 (en) * 2003-03-17 2004-09-30 Julius-Maximilians-Uni Versität Würzburg Nab proteins and their use in diagnostic and therapeutic applications in heart disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection

Also Published As

Publication number Publication date
NO20010166D0 (en) 2001-01-10
TR200100622T2 (en) 2001-10-22
AU763713B2 (en) 2003-07-31
ID27742A (en) 2001-04-26
EP1097200A1 (en) 2001-05-09
AU4791499A (en) 2000-02-01
NZ509174A (en) 2003-08-29
EE200100020A (en) 2002-06-17
YU1901A (en) 2005-06-10
BR9912018A (en) 2006-01-31
KR20010071832A (en) 2001-07-31
EA200100028A1 (en) 2001-08-27
CN1317045A (en) 2001-10-10
SK382001A3 (en) 2001-09-11
HUP0102835A3 (en) 2003-09-29
CA2336805A1 (en) 2000-01-20
NO20010166L (en) 2001-03-06
JP2002520020A (en) 2002-07-09
HRP20010025A2 (en) 2001-12-31
HUP0102835A2 (en) 2001-11-28
AP2001002038A0 (en) 2001-03-31
PL345507A1 (en) 2001-12-17
WO2000003014A1 (en) 2000-01-20
IL140533A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
NO20000852L (en) helical
NO991151D0 (en) Compound and Use thereof
DE69620260T2 (en) DETACHED INSULATION BODY
BR9706700A (en) Combined electronic clock
ATA151697A (en) ANGLE-STABLE SCREW CONNECTION
DE59808490D1 (en) PENIS EXTENSION UNIT
DK1398011T3 (en) ostomy devices
DK1140952T3 (en) Phosphorus-organic compounds and their use
DE69931296D1 (en) Channel-selecting device
DK0853933T3 (en) ostomy
IS5788A (en) Pharmacological use of NAB1 and NAB2
DE69828217D1 (en) High-frequency circuit element
DE29809884U1 (en) Wrist bandage
DE69831998D1 (en) Electronic clockwork
IS5636A (en) Treatment of irrational relapses
DE29700260U1 (en) condom
DE29618505U1 (en) condom
NO20010470D0 (en) Switching device and use of the same
DE69812105D1 (en) TAKING DEVICES
DE69908589D1 (en) REMOTE CALCULATION
DE29601061U1 (en) Warmer
DE29605563U1 (en) condom
DE29723930U1 (en) Insulation element
KR980000660U (en) Dumplings Warmer
IS5873A (en) Treatment of depression